UniProt ID | SYDC_HUMAN | |
---|---|---|
UniProt AC | P14868 | |
Protein Name | Aspartate--tRNA ligase, cytoplasmic | |
Gene Name | DARS | |
Organism | Homo sapiens (Human). | |
Sequence Length | 501 | |
Subcellular Localization | Cytoplasm, cytosol . | |
Protein Description | Catalyzes the specific attachment of an amino acid to its cognate tRNA in a 2 step reaction: the amino acid (AA) is first activated by ATP to form AA-AMP and then transferred to the acceptor end of the tRNA.. | |
Protein Sequence | MPSASASRKSQEKPREIMDAAEDYAKERYGISSMIQSQEKPDRVLVRVRDLTIQKADEVVWVRARVHTSRAKGKQCFLVLRQQQFNVQALVAVGDHASKQMVKFAANINKESIVDVEGVVRKVNQKIGSCTQQDVELHVQKIYVISLAEPRLPLQLDDAVRPEAEGEEEGRATVNQDTRLDNRVIDLRTSTSQAVFRLQSGICHLFRETLINKGFVEIQTPKIISAASEGGANVFTVSYFKNNAYLAQSPQLYKQMCICADFEKVFSIGPVFRAEDSNTHRHLTEFVGLDIEMAFNYHYHEVMEEIADTMVQIFKGLQERFQTEIQTVNKQFPCEPFKFLEPTLRLEYCEALAMLREAGVEMGDEDDLSTPNEKLLGHLVKEKYDTDFYILDKYPLAVRPFYTMPDPRNPKQSNSYDMFMRGEEILSGAQRIHDPQLLTERALHHGIDLEKIKAYIDSFRFGAPPHAGGGIGLERVTMLFLGLHNVRQTSMFPRDPKRLTP | |
Overview of Protein Modification Sites with Functional and Structural Information | ||
|
* ASA = Accessible Surface Area
Locations | Modification | Substrate Peptides & Secondary Structure |
ASA (%) | Reference | Orthologous Protein Cluster |
---|---|---|---|---|---|
3 | Phosphorylation | -----MPSASASRKS -----CCCHHCCCCC | 33.29 | 29759185 | |
5 | Phosphorylation | ---MPSASASRKSQE ---CCCHHCCCCCCC | 30.99 | 23312004 | |
7 | Phosphorylation | -MPSASASRKSQEKP -CCCHHCCCCCCCCC | 37.43 | 25106551 | |
10 | Phosphorylation | SASASRKSQEKPREI CHHCCCCCCCCCHHH | 42.32 | 28450419 | |
13 | Ubiquitination | ASRKSQEKPREIMDA CCCCCCCCCHHHHHH | 41.56 | - | |
18 | Sulfoxidation | QEKPREIMDAAEDYA CCCCHHHHHHHHHHH | 2.16 | 21406390 | |
24 | Phosphorylation | IMDAAEDYAKERYGI HHHHHHHHHHHHHCH | 15.86 | 20071362 | |
26 | Acetylation | DAAEDYAKERYGISS HHHHHHHHHHHCHHH | 36.17 | 23236377 | |
26 | Malonylation | DAAEDYAKERYGISS HHHHHHHHHHHCHHH | 36.17 | 26320211 | |
26 | Ubiquitination | DAAEDYAKERYGISS HHHHHHHHHHHCHHH | 36.17 | - | |
29 | Phosphorylation | EDYAKERYGISSMIQ HHHHHHHHCHHHHHC | 21.65 | 29449344 | |
32 | Phosphorylation | AKERYGISSMIQSQE HHHHHCHHHHHCCCC | 14.97 | 28857561 | |
33 | Phosphorylation | KERYGISSMIQSQEK HHHHCHHHHHCCCCC | 20.27 | 28857561 | |
34 | Sulfoxidation | ERYGISSMIQSQEKP HHHCHHHHHCCCCCC | 2.29 | 30846556 | |
37 | Phosphorylation | GISSMIQSQEKPDRV CHHHHHCCCCCCCCE | 29.40 | 29449344 | |
40 | Acetylation | SMIQSQEKPDRVLVR HHHCCCCCCCCEEEE | 44.58 | 23236377 | |
40 | Ubiquitination | SMIQSQEKPDRVLVR HHHCCCCCCCCEEEE | 44.58 | - | |
43 | Methylation | QSQEKPDRVLVRVRD CCCCCCCCEEEEEEE | 32.00 | - | |
52 | Phosphorylation | LVRVRDLTIQKADEV EEEEEECEECCCCEE | 26.17 | 30266825 | |
55 | Acetylation | VRDLTIQKADEVVWV EEECEECCCCEEEEE | 54.69 | 57530815 | |
63 | Methylation | ADEVVWVRARVHTSR CCEEEEEEEEEECHH | 10.85 | - | |
74 | Malonylation | HTSRAKGKQCFLVLR ECHHCCCCEEEEEEE | 43.09 | 26320211 | |
74 | Ubiquitination | HTSRAKGKQCFLVLR ECHHCCCCEEEEEEE | 43.09 | 19608861 | |
74 | Acetylation | HTSRAKGKQCFLVLR ECHHCCCCEEEEEEE | 43.09 | 19608861 | |
99 | Acetylation | AVGDHASKQMVKFAA EECCHHHHHHHHHHH | 43.10 | 25953088 | |
99 | Ubiquitination | AVGDHASKQMVKFAA EECCHHHHHHHHHHH | 43.10 | 21890473 | |
99 | Ubiquitination | AVGDHASKQMVKFAA EECCHHHHHHHHHHH | 43.10 | 21890473 | |
103 | Ubiquitination | HASKQMVKFAANINK HHHHHHHHHHHCCCH | 24.76 | 21890473 | |
103 | Acetylation | HASKQMVKFAANINK HHHHHHHHHHHCCCH | 24.76 | 23954790 | |
103 | Malonylation | HASKQMVKFAANINK HHHHHHHHHHHCCCH | 24.76 | 26320211 | |
103 | Ubiquitination | HASKQMVKFAANINK HHHHHHHHHHHCCCH | 24.76 | 21890473 | |
110 | Acetylation | KFAANINKESIVDVE HHHHCCCHHHCCCHH | 49.38 | 19816139 | |
110 | Ubiquitination | KFAANINKESIVDVE HHHHCCCHHHCCCHH | 49.38 | - | |
112 | Phosphorylation | AANINKESIVDVEGV HHCCCHHHCCCHHHH | 29.53 | 21406692 | |
126 | 2-Hydroxyisobutyrylation | VVRKVNQKIGSCTQQ HHHHHHHHHCCCCHH | 43.78 | - | |
126 | Acetylation | VVRKVNQKIGSCTQQ HHHHHHHHHCCCCHH | 43.78 | 25953088 | |
126 | Ubiquitination | VVRKVNQKIGSCTQQ HHHHHHHHHCCCCHH | 43.78 | - | |
130 | Glutathionylation | VNQKIGSCTQQDVEL HHHHHCCCCHHHHHH | 3.16 | 22555962 | |
143 | Phosphorylation | ELHVQKIYVISLAEP HHEEEEEEEEECCCC | 9.96 | 28152594 | |
146 | Phosphorylation | VQKIYVISLAEPRLP EEEEEEEECCCCCCC | 16.10 | 20068231 | |
188 | Methylation | DNRVIDLRTSTSQAV CCEEEEECCCCHHHH | 23.92 | - | |
200 | Phosphorylation | QAVFRLQSGICHLFR HHHHHHHHHHHHHHH | 34.42 | 21210654 | |
213 | 2-Hydroxyisobutyrylation | FRETLINKGFVEIQT HHHHHHHCCCEEECC | 46.89 | - | |
213 | Acetylation | FRETLINKGFVEIQT HHHHHHHCCCEEECC | 46.89 | 57530807 | |
220 | Phosphorylation | KGFVEIQTPKIISAA CCCEEECCCCEEEEC | 32.01 | 24702127 | |
225 | Phosphorylation | IQTPKIISAASEGGA ECCCCEEEECCCCCC | 22.66 | 20068231 | |
228 | Phosphorylation | PKIISAASEGGANVF CCEEEECCCCCCCEE | 36.17 | 21406692 | |
236 | Phosphorylation | EGGANVFTVSYFKNN CCCCCEEEEEEECCC | 12.31 | 28152594 | |
238 | Phosphorylation | GANVFTVSYFKNNAY CCCEEEEEEECCCEE | 23.07 | 28152594 | |
239 | Phosphorylation | ANVFTVSYFKNNAYL CCEEEEEEECCCEEE | 17.78 | 28152594 | |
241 | Acetylation | VFTVSYFKNNAYLAQ EEEEEEECCCEEECC | 40.85 | 57530811 | |
241 | Ubiquitination | VFTVSYFKNNAYLAQ EEEEEEECCCEEECC | 40.85 | - | |
245 | Phosphorylation | SYFKNNAYLAQSPQL EEECCCEEECCCHHH | 12.51 | 28152594 | |
249 | Phosphorylation | NNAYLAQSPQLYKQM CCEEECCCHHHHHHH | 14.70 | 19664994 | |
253 | Phosphorylation | LAQSPQLYKQMCICA ECCCHHHHHHHHHHC | 8.23 | 23403867 | |
254 | Acetylation | AQSPQLYKQMCICAD CCCHHHHHHHHHHCC | 39.90 | 26051181 | |
274 | Acetylation | SIGPVFRAEDSNTHR EECCEEECCCCCCCC | 17.30 | 19608861 | |
274 | Ubiquitination | SIGPVFRAEDSNTHR EECCEEECCCCCCCC | 17.30 | 19608861 | |
323 | Phosphorylation | GLQERFQTEIQTVNK HHHHHHHHHHHHHHH | 32.13 | 20068231 | |
327 | Phosphorylation | RFQTEIQTVNKQFPC HHHHHHHHHHHCCCC | 31.54 | 20068231 | |
330 | Ubiquitination | TEIQTVNKQFPCEPF HHHHHHHHCCCCCCC | 49.32 | 21890473 | |
330 | Acetylation | TEIQTVNKQFPCEPF HHHHHHHHCCCCCCC | 49.32 | 25953088 | |
330 | Ubiquitination | TEIQTVNKQFPCEPF HHHHHHHHCCCCCCC | 49.32 | 21890473 | |
338 | Ubiquitination | QFPCEPFKFLEPTLR CCCCCCCCCCCCCHH | 60.81 | - | |
343 | Phosphorylation | PFKFLEPTLRLEYCE CCCCCCCCHHHHHHH | 18.35 | 21712546 | |
362 | Sulfoxidation | LREAGVEMGDEDDLS HHHHCCCCCCCCCCC | 8.34 | 28183972 | |
369 | Phosphorylation | MGDEDDLSTPNEKLL CCCCCCCCCCCHHHH | 49.14 | - | |
370 | Phosphorylation | GDEDDLSTPNEKLLG CCCCCCCCCCHHHHH | 37.11 | 28985074 | |
374 | Acetylation | DLSTPNEKLLGHLVK CCCCCCHHHHHHHHH | 56.50 | 19608861 | |
374 | Ubiquitination | DLSTPNEKLLGHLVK CCCCCCHHHHHHHHH | 56.50 | 21906983 | |
381 | Ubiquitination | KLLGHLVKEKYDTDF HHHHHHHHHHCCCCE | 55.65 | - | |
383 | Ubiquitination | LGHLVKEKYDTDFYI HHHHHHHHCCCCEEE | 42.58 | - | |
383 | 2-Hydroxyisobutyrylation | LGHLVKEKYDTDFYI HHHHHHHHCCCCEEE | 42.58 | - | |
383 | Acetylation | LGHLVKEKYDTDFYI HHHHHHHHCCCCEEE | 42.58 | 27452117 | |
384 | Phosphorylation | GHLVKEKYDTDFYIL HHHHHHHCCCCEEEE | 25.76 | 25884760 | |
386 | Phosphorylation | LVKEKYDTDFYILDK HHHHHCCCCEEEEEC | 25.56 | - | |
389 | Phosphorylation | EKYDTDFYILDKYPL HHCCCCEEEEECCCC | 11.91 | 25884760 | |
393 | Ubiquitination | TDFYILDKYPLAVRP CCEEEEECCCCEEEC | 45.37 | - | |
394 | Phosphorylation | DFYILDKYPLAVRPF CEEEEECCCCEEECC | 11.80 | 24719451 | |
402 | Phosphorylation | PLAVRPFYTMPDPRN CCEEECCCCCCCCCC | 12.57 | 25884760 | |
403 | Phosphorylation | LAVRPFYTMPDPRNP CEEECCCCCCCCCCC | 23.70 | 24719451 | |
411 | Acetylation | MPDPRNPKQSNSYDM CCCCCCCCCCCCCCC | 70.66 | 25953088 | |
411 | Ubiquitination | MPDPRNPKQSNSYDM CCCCCCCCCCCCCCC | 70.66 | - | |
413 | Phosphorylation | DPRNPKQSNSYDMFM CCCCCCCCCCCCCHH | 33.59 | 21406692 | |
415 | Phosphorylation | RNPKQSNSYDMFMRG CCCCCCCCCCCHHCH | 27.97 | 21406692 | |
416 | Phosphorylation | NPKQSNSYDMFMRGE CCCCCCCCCCHHCHH | 18.71 | 21406692 | |
427 | Phosphorylation | MRGEEILSGAQRIHD HCHHHHHHHHCCCCC | 37.43 | 21406692 | |
451 | Acetylation | HHGIDLEKIKAYIDS HCCCCHHHHHHHHHH | 57.72 | 23954790 | |
451 | 2-Hydroxyisobutyrylation | HHGIDLEKIKAYIDS HCCCCHHHHHHHHHH | 57.72 | - | |
451 | Ubiquitination | HHGIDLEKIKAYIDS HCCCCHHHHHHHHHH | 57.72 | - | |
453 | 2-Hydroxyisobutyrylation | GIDLEKIKAYIDSFR CCCHHHHHHHHHHHC | 46.32 | - | |
453 | Acetylation | GIDLEKIKAYIDSFR CCCHHHHHHHHHHHC | 46.32 | 57530803 | |
453 | Ubiquitination | GIDLEKIKAYIDSFR CCCHHHHHHHHHHHC | 46.32 | - | |
478 | Sulfoxidation | IGLERVTMLFLGLHN CCHHHHHHHHHCCCC | 1.97 | 28183972 | |
490 | Phosphorylation | LHNVRQTSMFPRDPK CCCCCCCCCCCCCCC | 15.30 | 28857561 | |
500 | Phosphorylation | PRDPKRLTP------ CCCCCCCCC------ | 30.87 | 24719451 |
Modified Location | Modified Residue | Modification | Type of Upstream Proteins | Gene Name of Upstream Proteins | UniProt AC of Upstream Proteins | Sources |
---|---|---|---|---|---|---|
500 | T | Phosphorylation | Kinase | PKA | - | Uniprot |
Modified Location | Modified Residue | Modification | Function | Reference | ||
---|---|---|---|---|---|---|
Oops, there are no descriptions of PTM sites of SYDC_HUMAN !! |
* Distance = the distance between SAP position and PTM sites.
Modified Location | Modification | Variant Position (Distance <= 10) |
Residue Change | SAP | Related Disease | Reference |
---|---|---|---|---|---|---|
Oops, there are no SNP-PTM records of SYDC_HUMAN !! |
loading...
Acetylation | |
Reference | PubMed |
"Lysine acetylation targets protein complexes and co-regulates majorcellular functions."; Choudhary C., Kumar C., Gnad F., Nielsen M.L., Rehman M., Walther T.,Olsen J.V., Mann M.; Science 325:834-840(2009). Cited for: ACETYLATION [LARGE SCALE ANALYSIS] AT LYS-74 AND LYS-374, AND MASSSPECTROMETRY. | |
Phosphorylation | |
Reference | PubMed |
"Lys-N and trypsin cover complementary parts of the phosphoproteome ina refined SCX-based approach."; Gauci S., Helbig A.O., Slijper M., Krijgsveld J., Heck A.J.,Mohammed S.; Anal. Chem. 81:4493-4501(2009). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-249, AND MASSSPECTROMETRY. | |
"Automated phosphoproteome analysis for cultured cancer cells by two-dimensional nanoLC-MS using a calcined titania/C18 biphasic column."; Imami K., Sugiyama N., Kyono Y., Tomita M., Ishihama Y.; Anal. Sci. 24:161-166(2008). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-238, AND MASSSPECTROMETRY. |